Acetyl coenzyme A
MolecularEntityThe metabolic convergence point where glucose, fatty acid, and amino acid catabolism each deliver a two-carbon acetyl unit.
Where beauty meets biology
13 entities found starting with A Clear filters
The metabolic convergence point where glucose, fatty acid, and amino acid catabolism each deliver a two-carbon acetyl unit.
A biomimetic neuro-modulatory peptide that reduces expression lines by competing with the SNARE complex, offering a non-invasive alternative to botulinum toxin.
The dynamically maintained acidic pH environment of the stratum corneum. Controls ceramide processing, desquamation timing, antimicrobial defence, and microbiome composition simultaneously.
The enzyme that converts sphingomyelin to ceramide via the sphingomyelinase pathway. Active in both lamellar body secretion and UV-induced keratinocyte stress signalling.
A chronic inflammatory disease of the pilosebaceous unit producing follicular hyperkeratinisation, seborrhoea, C. acnes phylotype dysbiosis, and immune activation.
Adipocytes are energy‑storing endocrine cells that release fatty acids and adipokines to regulate metabolism, inflammation, and whole‑body metabolic health.
The hypothalamic neuropeptide that drives sustained food-seeking by blocking and actively suppressing melanocortin-4 receptor activity.
The molecular building blocks from which every structural and functional protein in the skin is assembled. Collagen, elastin, keratin, and filaggrin are all amino acid sequences.
The cell's master energy sensor: a heterotrimeric kinase that detects rising AMP:ATP ratios and systematically switches metabolism from anabolic to catabolic programmes.
Active hair growth phase lasting 2-7 years; normally 85-90% of your follicles are in this growth-producing state.
Progressive genetic hair loss where follicles gradually miniaturise, shortening growth phases and producing finer, thinner hairs.
Endogenous peptides that defend against microbes yet can drive inflammation, acting as antimicrobial, immunomodulatory, and microbiome‑shaping signals.
The terminal pro-inflammatory omega-6 fatty acid, produced from DGLA. Feeds the eicosanoid pathways that drive vasodilation, immune cell recruitment, and inflammatory skin conditions.